[{"Assets_0_Q3_USD":329487000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-151683000.0,"NetIncomeLoss_1_Q3_USD":-30722000.0,"NetIncomeLoss_3_Q3_USD":-100672000.0,"StockholdersEquity_0_Q3_USD":78376000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]